SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMhp Reg S Regulatory News (MHPC)

Share Price Information for Mhp Reg S (MHPC)

Share Price is delayed by 15 minutes
Get Live Data
8.98    0.18 (2.05%)
Bid:
8.46
Ask:
8.72
Spread: 0.26 (3.073%)
Market Cap: $961.20m
MHPC Live PriceLast checked at - London Stock Exchange

Intraday Mhp Reg S Share Chart

  • This share is an international stock.

Tender Offer Results Announcement

9 Apr 2018 14:46

RNS Number : 3065K
MHP SE
09 April 2018
 

NOT FOR DISTRIBUTION IN OR INTO OR TO ANY PERSON LOCATED OR RESIDENT IN ANY JURISDICTION WHERE IT IS UNLAWFUL TO DISTRIBUTE THIS ANNOUNCEMENT.

9 April 2018

MHP SE ANNOUNCES RESULTS OF TENDER OFFER

Further to its announcement on 3 April, MHP SE (the "Company") today announces that (i) holders ("Noteholders") validly tendered U.S.$6,400,000 in aggregate principal amount of the Company's 8.25% Notes due 2 April 2020 (the "Notes") into its previously announced cash tender offer (the "Tender Offer") following the Early Tender Deadline, (ii) the Company has accepted for purchase all validly tendered Notes as set forth in the table below and (iii) the aggregate principal amount of Notes outstanding following completion of the Tender Offer is U.S.$79,417,000. The Tender Offer was made on the terms and conditions as set forth in a tender offer memorandum dated 9 March 2018 (the "Tender Offer Memorandum") in accordance with the procedures described therein. Capitalized terms used but not otherwise defined in this announcement have the same meanings given to them in the Tender Offer Memorandum.

Description of the Notes

Regulation S Notes

Rule 144A Notes

Principal Amount of Notes Accepted for Purchase in the Tender Offer1

Outstanding Principal Amount Following Settlement of the Tender Offer

U.S.$750,000,000 8.25% Notes due 2 April 2020

Common Code 091050617 / ISIN: USL6366MAC75 / CUSIP: L6366MAC7

Common Code 078395079 / ISIN: US55302TAC99 / CUSIP: 55302TAC9

U.S.$416,183,000

U.S.$79,417,000

1. Includes U.S.$409,783,000 in aggregate principal amount of Notes tendered and accepted prior to the Early Tender Deadline and U.S.$6,400,000 in aggregate principal amount of Notes tendered following the Early Tender Deadline

On or about 10 April 2018, on the terms and subject to the conditions in the Tender Offer Memorandum, Noteholders who validly tendered following the Early Tender Deadline and on or before the Expiration Deadline will be paid the Tender Offer Consideration of U.S.$1,065 per U.S.$1,000 principal amount plus the Accrued Interest Amount from (and including) the immediately preceding interest payment date for the Notes up to but not including the Final Payment Date.

The Tender Offer has now expired and no further Notes can be tendered for purchase.

The Notes acquired in the Tender Offer will be cancelled. Notes that have not been successfully tendered for purchase and accepted by the Company pursuant to the Tender Offer will remain outstanding and will remain subject to the indenture governing the Notes.

For Further Information

Further details about the Tender Offer can be obtained from:

The Joint Dealer Managers

ING Bank N.V., London Branch

8-20 Moorgate

London EC2R 6DA

United Kingdom

Telephone: +31 20 563 8017

Email: liability.management@uk.ing.com

Attention: Liability Management

J.P. Morgan Securities plc

25 Bank Street

Canary Wharf

London E14 5JP

United Kingdom

Telephone: +44 20 7134 2468

E-mail: em_europe_lm@jpmorgan.com

Attention: Liability Management

UBS Limited

5 Broadgate

London EC2M 2QS

United Kingdom

Telephone: +44 20 7568 2133

Attention: Liability Management Group

Email: ol-liabilitymanagement-eu@ubs.com

The Information and Tender Agent

D.F. King Limited

Email: MHP@dfkingltd.comTender Offer Website: https://sites.dfkingltd.com/mhp

In London:

125 Wood Street

London EC2V 7AN

United Kingdom

Telephone: +44 20 7920 9700

 

In New York

48 Wall Street, 22nd Floor

New York, New York 10005

United States

Banks and Brokers call: +1 212 269 5550

All others call Toll-Free: +1 800 848 3405

By Facsimile Transmission (for Eligible Institutions only): +1 212 709 3328

For Confirmation: +1 212 269 5552

Attention: Andrew Beck

In Hong Kong

Suite 1601, 16/F, Central Tower

28 Queen's Road Central

Hong Kong

Telephone: +852 3953 7230

 

This announcement has been issued through the Companies Announcement Service of Euronext Dublin.

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
ISEEADLNELSPEFF
Date   Source Headline
1st Jun 20267:00 amRNSMHP SE to acquire up to 100% of Th. Nitsiakos AVEE
8th May 20267:34 amRNSMHP SE Notice of Annual General Meeting
5th May 20267:04 amRNSFinancial Results for the Q4 and 12M
17th Feb 20261:10 pmRNSMHP 2026 NOTES REDEMPTION PRICE ANNOUNCEMENT
13th Feb 20269:34 amRNSMHP LUX S.A. ANNOUNCES RESULTS OF TENDER OFFER
10th Feb 202610:32 amRNSMHP SE TAP OFFERING CLOSING ANNOUNCEMENT
4th Feb 20267:00 amRNSMHP Tap Pricing Announcement
3rd Feb 20269:11 amRNSMHP Tap Launch Announcement
28th Jan 202611:21 amRNSMHP NEW EUROBOND CLOSING ANNOUNCEMENT
22nd Jan 20267:00 amRNSMHP SE - Eurobond 2026 - Pricing Announcement
15th Jan 20261:28 pmRNSMHP 2026 NOTES CONDITIONAL REDEMPTION ANNOUNCEMENT
15th Jan 20261:12 pmRNSMHP SE NEW EUROBOND MANDATE AND TENDER OFFER
15th Jan 202612:57 pmRNSMHP LUX S.A. - INVITATION TO PURCHASE NOTES
15th Dec 20257:00 amRNSMHP SE Financial Results for the Q3 and 9 M 2025
9th Dec 20252:07 pmRNSMHP SE Results of EGM 09 December 2025
14th Nov 20252:14 pmRNSNotification about GDRs Purchase by PDMR of MHP
7th Nov 20258:25 amRNSConvening Notice of Extraordinary General Meeting
12th Sep 20257:00 amRNSFinancial Results for the Q2 and 6M 2025
4th Aug 20257:00 amRNSMHP Closes Acquisition of 92% Stake in Grupo UVESA
16th Jun 20251:39 pmRNSMHP SE Results of AGM 2025
21st May 20257:00 amRNSFinancial Results for the First Quarter 2025
14th May 20258:58 amRNSNotice of Annual General Meeting 2025
28th Apr 20257:09 amRNSFinancial Results Q4 and 12M 2024
28th Apr 20257:00 amRNSMHP acquires 91.77% of UVESA
21st Mar 20257:00 amRNSMHP signs Share Purchase Agreement with UVESA
11th Dec 20247:00 amRNSMHP offers to acquire UVESA Group
10th Dec 20241:08 pmRNSPress release on EGM result
22nd Nov 20247:10 amRNSFinancial Results for Q3 and 9M 2024
5th Nov 202411:33 amRNSNotice of Extraordinary General Meeting
17th Sep 202412:31 pmRNSDisclosure Notification
6th Sep 20249:29 amRNSFinancial Results for Q2 and 6M 2024 replace
19th Jun 202410:34 amRNSResults of AGM
4th Jun 20247:37 amRNSFinancial Results for the First Quarter 2024
17th May 20248:47 amRNSConvening Notice - AGM 2024
17th May 20247:22 amRNSBoard Changes
10th May 20247:58 amRNS2024 Eurobond Repayment
2nd May 20247:30 amRNS2023 Integrated Annual Report and Press Statement
11th Mar 20241:02 pmRNSEGM Results
7th Feb 202412:41 pmRNSEGM- Convening Notice
23rd Jan 20249:54 amRNSAppointment of a new ARC Chair
16th Nov 20237:13 amRNSQ3 and 9M 2023 Financial Results
25th Sep 20239:02 amRNSFinancial Statement Q2 2023
21st Sep 20237:06 amRNSDate Notification Q2 2023 Results
8th Sep 20237:00 amRNSMHP SE Invests in Saudi Arabia
19th Jun 20238:41 amRNSAGM results
18th May 20237:00 amRNSQ1 2023 Financial and Operational Results
17th May 202311:00 amRNSAGM Convening Notice
11th Apr 20239:42 amRNSMHP SE Standalone FS 2022
11th Apr 20239:27 amRNSMHP SE Standalone FS 2022
11th Apr 20238:54 amRNSMHP SE Standalone 2022

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.